U.S. Markets closed

cbdMD, Inc. (YCBD)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
2.2900+0.0800 (+3.62%)
At close: 4:00PM EDT

cbdMD, Inc.

8845 Red Oak Boulevard
Charlotte, NC 28217
United States
704-445-3060
http://www.cbdmd.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees182

Key Executives

NameTitlePayExercisedYear Born
Mr. Martin A. SumichrastChairman & Co-CEO504.12kN/A1967
Mr. Raymond Scott CoffmanCo-Founder, Pres, Co- CEO & Director167.93kN/A1962
Mr. Mark S. ElliottCFO & COO319.85kN/A1961
Lance BlundellGen. CounselN/AN/AN/A
Mr. Ken CohnChief Marketing OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

cbdMD, Inc. produces and distributes various cannibidiol (CBD) products. It owns and operates the consumer hemp-based CBD brand, cbdMD. The company's product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name. The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.

Corporate Governance

cbdMD, Inc.’s ISS Governance QualityScore as of December 9, 2019 is 6. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.